# Jennifer Fried

> Jennifer Fried is a seed investor at Portfolia (Chicago) backing Health Care and Medical Device. See 12 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Portfolia](https://shizune.co/investors/profile/portfolia)
- Location: Chicago, United States
- Total investments: 12
- Last investment: Mar 2022
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/friedjennifer

Jennifer Fried is a seed investor at Portfolia in Chicago focused on Health Care and Medical Device. Jennifer Fried is the CEO & Co-Founder of ExplORer Surgical .

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.1M–$4.3M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 42% |
| Medical Device | 4 | 33% |
| Women's | 3 | 25% |
| Medical | 2 | 17% |
| Wellness | 2 | 17% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 25% |
| Series A | 3 | 25% |
| Series B | 1 | 8% |
| Series C | 1 | 8% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nest Collaborative | Nest Collaborative is a provider of on-demand lactation counseling services intended to offer a collection of international board certified lactation consultants who conduct online, video appointments to help guide moms through the breastfeeding process. The company's services are offered via an online platform that offers reimbursed maternal,neonatal and lactation counseling services, enabling women to avail safe, convenient and affordable access to quality pediatric care, at home. | $4.3M | Seed | Mar 15, 2022 |  |
| Proov | Proov offers patented at home testing systems - including the only FDA cleared at-home test to measure progesterone metabolite PdG - to help women understand and act on their hormones.When used with the Proov Insight app, Proov's easy, at-home pee tests provide a science-backed fertility coach right in your hand. First, a woman can measureall of the menstrual hormones daily with Proov tests, then snap a photo of each test within the Insight app. Then, a woman can follow the in-app prompts throughout her cycle to understand ovulation status, get daily insights and an Ovulation Insights score. Finally, the app generates a personalized action plan to maximize her wellness or develop a fertility strategy. Proov was founded by Amy Beckley, Ph.D, the "infertile scientist," after three years of infertility and seven miscarriages. Amy applied her own science expertise to uncover a luteal phase defect (a problem with ovulation quality). With help from her doctor and a simple supplement, Amy was able to get pregnant with her daughter.Proov is a venture capital backed company and the leader in understanding hormone health on the basis of tracking PdG, a metabolite of progesterone. | $9.7M | Series A | Dec 15, 2021 |  |
| Willow | Willow is a female technology company that develops an in-bra wearable breast pump, replacement parts, breastfeeding essentials, pumping bras, cases and bags, breastfeeding essentials, and more. | $26.8M | Series C | Apr 21, 2021 |  |
| Nest Collaborative | Nest Collaborative is a provider of on-demand lactation counseling services intended to offer a collection of international board certified lactation consultants who conduct online, video appointments to help guide moms through the breastfeeding process. The company's services are offered via an online platform that offers reimbursed maternal,neonatal and lactation counseling services, enabling women to avail safe, convenient and affordable access to quality pediatric care, at home. | $2.1M | Seed | Feb 17, 2021 |  |
| Nest Collaborative | Nest Collaborative is a provider of on-demand lactation counseling services intended to offer a collection of international board certified lactation consultants who conduct online, video appointments to help guide moms through the breastfeeding process. The company's services are offered via an online platform that offers reimbursed maternal,neonatal and lactation counseling services, enabling women to avail safe, convenient and affordable access to quality pediatric care, at home. |  | Seed | Feb 12, 2021 |  |
| Madorra | Madorra Their goal is empowering women to live fuller, healthier lives. Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power tochoose the non-hormonal treatment option they want. |  | Seed | Dec 01, 2020 |  |
| Madorra | Madorra Their goal is empowering women to live fuller, healthier lives. Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power tochoose the non-hormonal treatment option they want. |  | Series A | Dec 01, 2020 |  |
| Solace Therapeutics | Solace Therapeutics is a medical device company that develops and commercializes non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). It is dedicated to improving the patient’s quality of life byeliminating side effects typically associated with current drug and surgical therapies.The company offers a technology that is designed to offer patients an office-based therapy that does not require anesthesia or surgery, no lifestyle change required, before or after treatment, and reversible at any time. |  | Seed | Apr 01, 2020 |  |
| Solace Therapeutics | Solace Therapeutics is a medical device company that develops and commercializes non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). It is dedicated to improving the patient’s quality of life byeliminating side effects typically associated with current drug and surgical therapies.The company offers a technology that is designed to offer patients an office-based therapy that does not require anesthesia or surgery, no lifestyle change required, before or after treatment, and reversible at any time. |  | Seed | Apr 01, 2020 |  |
| Solace Therapeutics | Solace Therapeutics is a medical device company that develops and commercializes non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). It is dedicated to improving the patient’s quality of life byeliminating side effects typically associated with current drug and surgical therapies.The company offers a technology that is designed to offer patients an office-based therapy that does not require anesthesia or surgery, no lifestyle change required, before or after treatment, and reversible at any time. |  | Series A | Apr 01, 2020 |  |

10 of 12 investments shown.

## Co-investors
- [Portfolia](https://shizune.co/investors/profile/portfolia) — VC Fund, 7 deals together
- [Wavemaker 360](https://shizune.co/investors/profile/wavemaker-360) — VC Fund, 3 deals together
- [Altitude Ventures](https://shizune.co/investors/profile/altitude-ventures) — VC Fund, 2 deals together
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 2 deals together
- [Hustle Fund](https://shizune.co/investors/profile/hustle-fund) — VC Fund, 2 deals together
- [Bread and Butter Ventures](https://shizune.co/investors/profile/the-syndicate-fund) — VC Fund, 2 deals together

## About Portfolia

VC Fund · San Mateo, United States

Portfolia connects sophisticated investors and leaders with entrepreneurial companies. Their platform enables users to collaborate with other members and lead investors to evaluate innovative products and teams, join diligence teams, and immerse themselves in the investment process. It is an investment fund designed for women while backinginnovative companies for returns and impact.

5 contacts available at Portfolia.

| Name | Title | Profile |
| --- | --- | --- |
| Amber Caska | Investment Committee Member | https://shizune.co/investors/profile/amber-caska |
| Trish Costello | Founder & CEO | https://shizune.co/investors/profile/trish-costello |
| Valentina Vitols | Limited Partner | https://shizune.co/investors/profile/valentina-vitols |
| Abbe Kligerman | Limited Partner | https://shizune.co/investors/profile/abbe-kligerman-f3fd |
| Bethann Kassman | Deal Lead | https://shizune.co/investors/profile/bethann-kassman |

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Medical Device Angel Investors](https://shizune.co/investors/medical-device-angel-investors)
- [Medical Device Angel Investors in United States](https://shizune.co/investors/medical-device-angel-investors-united-states)

## FAQ

### What does Jennifer Fried invest in?

Jennifer Fried invests primarily in Health Care, Medical Device and Women's startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Jennifer Fried's check size?

Jennifer Fried typically joins rounds of $2.1M–$4.3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jennifer Fried participates in.

### When did Jennifer Fried last invest?

The most recent investment recorded for Jennifer Fried closed in Mar 2022. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co